Skip to main navigation Skip to search Skip to main content

ML43702: Long-Term Follow-Up Study Of Patients With Spinal Muscular Atrophy Receiving Risdiplam Treatment

Grants and Contracts Details

StatusActive
Effective start/end date2/22/232/22/27

Funding

  • Genentech Inc: $26,017.00